Profile data is unavailable for this security.
About the company
Zhaoke Ophthalmology Ltd is an investment holding company principally engaged in the development, manufacturing and marketing of ophthalmic drugs and products. The product pipelines primarily include NVK002 (Atropine) for myopia, CsA Ophthalmic Gel for DED and TAB014 (Bevacizumab) for wAMD. The products are primarily uses to treat eye diseases across both the front and the back of the eye, including dry eye disease (DED), myopia, presbyopia, wet age-related macular degeneration (wAMD) and diabetic macular edema (DME), glaucoma and corneal epithelial dysfunction (CED). The Company conducts its business in the domestic market and overseas markets.
- Revenue in HKD (TTM)40.00m
- Net income in HKD-314.86m
- Incorporated2020
- Employees270.00
- LocationZhaoke Ophthalmology LtdNo. 1 Meide 3rd Road, Pearl RiverIndustrial Park, Nansha DistrictGUANGZHOU ChinaCHN
- Phone+86 2 039062888
- Websitehttps://www.zkoph.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3D Medicines Inc | 507.27m | -190.63m | 1.05bn | 183.00 | -- | 1.29 | -- | 2.06 | -0.7781 | -0.7781 | 2.07 | 3.14 | 0.3728 | 7.53 | 6.78 | 2,655,869.00 | -14.79 | -- | -21.47 | -- | 92.11 | -- | -39.68 | -- | 1.59 | -- | 0.205 | -- | -29.81 | -- | 65.19 | -- | -- | -- |
| Transcenta Holding Ltd | 10.64m | -301.33m | 1.05bn | 171.00 | -- | 1.30 | -- | 98.49 | -0.7437 | -0.7437 | 0.0263 | 1.80 | 0.0075 | 0.3793 | 0.4927 | 57,844.45 | -21.21 | -32.48 | -30.08 | -41.13 | 34.76 | 22.08 | -2,831.15 | -1,072.37 | 0.4387 | -408.75 | 0.2437 | -- | -79.09 | -23.91 | 37.24 | -- | -60.12 | -- |
| Meilleure Health Intrntnl Indu Grp Ltd | 38.10m | 39.17m | 1.08bn | 49.00 | 27.60 | 0.8898 | -- | 28.44 | 0.0096 | 0.0096 | 0.0093 | 0.2978 | 0.0223 | 0.0363 | 0.9608 | 828,173.90 | 2.28 | 2.74 | 2.60 | 3.02 | 72.64 | 47.18 | 102.27 | 28.59 | 2.39 | -- | 0.2211 | 41.83 | -60.81 | -26.41 | -20.45 | -- | -1.03 | -- |
| Jilin Provnc Hnn Chnglng Bio-pharm CoLtd | 1.05bn | 207.00m | 1.13bn | 798.00 | 5.47 | 0.5774 | 4.71 | 1.08 | 0.3695 | 0.3695 | 1.87 | 3.50 | 0.3698 | 2.30 | 3.34 | 1,407,584.00 | 7.30 | 7.46 | 10.54 | 10.45 | 78.95 | 77.80 | 19.74 | 20.45 | 1.42 | -- | 0.0422 | 44.00 | 4.71 | 6.41 | 24.32 | 4.95 | -8.31 | -- |
| Beijing Biostar Pharmaceuticals Co Ltd | -100.00bn | -100.00bn | 1.37bn | 147.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 7.85 | -- | 24.19 | -- | -- | -- |
| Dawnrays Pharmaceutical (Holdings) Ltd | 1.26bn | 199.64m | 1.82bn | 1.12k | 9.13 | 0.4867 | 6.15 | 1.44 | 0.1326 | 0.1326 | 0.8362 | 2.49 | 0.2809 | 2.47 | 7.96 | 1,064,644.00 | 4.36 | 10.98 | 5.07 | 13.75 | 45.76 | 55.52 | 15.53 | 32.76 | 4.21 | -- | 0.0028 | 31.01 | -7.89 | 2.22 | 73.29 | 17.20 | 17.13 | 2.69 |
| Cutia Therapeutics | 283.20m | -534.29m | 1.86bn | 298.00 | -- | 1.92 | -- | 6.56 | -1.70 | -1.70 | 0.9013 | 2.67 | 0.1908 | 2.55 | 5.57 | 850,454.10 | -36.00 | -- | -44.42 | -- | 34.92 | -- | -188.66 | -- | 2.92 | -- | 0.2774 | -- | 103.17 | -- | 77.91 | -- | -- | -- |
| Zhaoke Ophthalmology Ltd | 40.00m | -314.86m | 1.90bn | 270.00 | -- | 0.979 | -- | 47.40 | -0.5691 | -0.5691 | 0.0724 | 3.53 | 0.0159 | 1.38 | 9.25 | 136,057.50 | -12.50 | -38.02 | -14.65 | -41.79 | 49.28 | -- | -787.13 | -4,412.89 | 4.36 | -29.83 | 0.1373 | -- | 269.73 | -- | 38.32 | -- | 18.80 | -- |
| Jbm (Healthcare) Ltd | 812.98m | 216.39m | 2.29bn | 412.00 | 10.50 | 2.13 | 8.26 | 2.82 | 0.2657 | 0.2657 | 0.9984 | 1.31 | 0.5111 | 3.76 | 5.05 | 2,913,918.00 | 14.09 | 6.57 | 17.00 | 7.83 | 56.76 | 47.82 | 27.56 | 16.60 | 2.41 | -- | 0.2486 | 53.40 | 20.65 | 15.44 | 51.20 | 36.90 | 35.96 | -- |
| Hangzhou Jiuyuan Genetic Biopharm Co Ltd | 1.48bn | 139.63m | 2.31bn | 1.63k | 14.82 | 1.30 | 12.42 | 1.57 | 0.6464 | 0.6464 | 7.23 | 7.36 | 0.7509 | 1.55 | 2.17 | 958,496.20 | 7.10 | -- | 8.88 | -- | 81.67 | -- | 9.45 | -- | 4.03 | 46.31 | 0.1058 | -- | 6.35 | -- | 15.72 | -- | -- | -- |
| Golden Throat Holdings Group Co Ltd | 1.11bn | 303.31m | 2.35bn | 842.00 | 7.75 | 1.72 | 6.90 | 2.12 | 0.4103 | 0.4103 | 1.50 | 1.85 | 0.467 | 2.29 | 5.32 | 1,268,143.00 | 12.78 | 11.71 | 21.02 | 16.75 | 76.42 | 73.08 | 27.37 | 25.87 | 1.73 | 21.95 | 0.3616 | 94.67 | 23.26 | 8.25 | 27.37 | 13.71 | -12.27 | 34.38 |
| Essex Bio-Technology Ltd | 1.73bn | 313.18m | 2.52bn | 1.43k | 8.08 | 1.11 | 6.81 | 1.45 | 0.5508 | 0.5508 | 3.05 | 4.01 | 0.5596 | 2.96 | 2.84 | 1,196,360.00 | 10.10 | 10.28 | 13.56 | 13.62 | 89.50 | 87.73 | 18.05 | 18.70 | 1.82 | -- | 0.1135 | 17.49 | -3.87 | 5.47 | 11.61 | 0.3101 | -7.47 | 7.14 |
| Jacobson Pharma Corporation Ltd | 1.53bn | 302.58m | 2.54bn | 1.79k | 8.36 | 1.14 | 5.63 | 1.66 | 0.1519 | 0.1519 | 0.7698 | 1.12 | 0.4299 | 2.54 | 9.06 | 876,757.00 | 8.48 | 4.83 | 10.29 | 6.17 | 44.30 | 41.26 | 19.73 | 14.85 | 0.9023 | 10.21 | 0.286 | 57.09 | 7.43 | 0.0691 | 43.09 | 7.05 | 24.09 | 14.87 |
| SinoMab Bioscience Ltd | 0.00 | -163.29m | 2.70bn | 61.00 | -- | 8.53 | -- | -- | -0.1508 | -0.1508 | 0.00 | 0.2285 | 0.00 | -- | -- | 0.00 | -18.46 | -22.26 | -24.62 | -25.68 | -- | -- | -- | -3,832.94 | -- | -7.82 | 0.6265 | -- | 48.42 | -- | 23.85 | -- | -0.376 | -- |
Data as of Feb 16 2026. Currency figures normalised to Zhaoke Ophthalmology Ltd's reporting currency: Hong Kong Dollar HKD
5.89%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| FIL Investment Management (Hong Kong) Ltd.as of 21 Aug 2025 | 32.27m | 5.89% |
Data from 30 Sep 2025 - 30 Sep 2025Source: FactSet Research Systems Inc.
